Manish Goel

Manish Goel - SEBI Registered Research Analyst

About Manish Goel

SEBI Registered Research Analyst • Chartered Accountant

377 Articles Published

Manish Goel is a Chartered Accountant, SEBI Registered Research Analyst, and founder of Manish Goel PMS. A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.

April 19, 2026
Infographic: segment-wise revenue breakdown bar chart from FY20 to FY25, dark blue background, green highlight for FY25; values shown at bar ends (28, 26, 22, 18, 14, 11). Title reads 'Segment-Wise Revenue Breakdown' with subtitle italic text beneath.

Segment-Wise Revenue Breakdown

Titan Biotech disclosed only one primary operating segment in FY25, a quiet but powerful sign that the business remains easier to understand and monitor than many small-cap peers.
April 19, 2026
Hero header for a article titled 'Overconfidence Bias' with a subtitle about Indian traders; decorative blue background with green accents.

Overconfidence Bias: Why 93% of Indian F&O Traders Lose Money — How Barber & Odean’s Landmark Research, Validated by SEBI’s 2024 Evidence, Explains the Zerodha-Groww Revolution and the Anti-Overconfidence Checklist Every Serious Long-Term Investor Must Adopt

Barber & Odean's Nobel-adjacent 2000 study, validated by SEBI's 2024 evidence that ~93% of Indian retail F&O traders lose money, explains the meta-bias that makes every other cognitive error worse — and the 8-question pre-trade checklist that disarms it.
April 19, 2026
Hero section titled 'Board Composition and Corporate Governance' with a green subtitle, featuring a five-year timeline (FY21–FY25) of milestones: Compliance, Disclosure, Audit clean, Board change, All boxes.

Board Composition and Corporate Governance

Titan Biotech ended FY25 with an 11-member board, four independent directors, an independent chair, and 14 board meetings - a governance structure that merits serious attention from long-term investors.
April 19, 2026
Bar chart of deferred tax by fiscal year from FY20 to FY25, values: 28, 26, 22, 18, 14, 11; FY25 bar is green.

Deferred Tax: The Accounting Line Item That Can Mislead Even Experienced Investors

Deferred tax can quietly change how reported profit should be read. The line is less about jargon and more about timing, profit quality, and whether management disclosure deserves trust.
+91-7380122211